Elizabeth Belloli is a Respiratory physician affiliated with University of Michigan. OpenAlex indexes 57 publications with 2,216 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1500 East Medical Center Dr.
3rd Floor Taubman Center Recp C
Ann Arbor, MI 481095360
Telephone
734-647-9342Registry record last updated 1 Jul 2015.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20256 payments
- Boehringer Ingelheim International GmbHProgram year20241 payment
- ANI Pharmaceuticals, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
27.6%Kinase inhibitor11.7%Ofev95%Everolimus5%Part D<11 patientsPyridone8.1%Pirfenidone100%Part D≥23 patients+ 3 more classes in this area
Anti-infectives
19.5%Macrolide Antimicrobial8.1%Azithromycin100%Part D≥40 patientsShort-acting sulfonamides5.8%Sulfamethoxazole-Trimethoprim100%Part D≥31 patients+ 4 more classes in this area
Metabolism & gastrointestinal
17.9%Corticosteroid11.8%Prednisone100%Part D≥57 patientsProton pump inhibitor4.1%Omeprazole85%Pantoprazole Sodium16%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine
2025 - Performance Characteristics for Physiological Measures of Progressive Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine
2025 - Safety and Tolerability of SGLT‐2 Inhibitors Following Lung Transplantation
Clinical Transplantation
2025 - A Quantitative Imaging Measure of Progressive Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine
2025 - Belatacept with Calcineurin Inhibitor Elimination in Lung Transplant Recipients with Calcineurin Inhibitor Renal Toxicities
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”